Life Sciences

Maat Pharma and Skyepharma have entered a partnership to establish the first exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France
14 February 2022

Maat Pharma and Skyepharma have entered a partnership to establish the first exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France

MaaT Pharma (EURONEXT: MAAT), a French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival...

Read the press release
The start-up La Vie™ raises €25M and sets out to conquer the world with its new generation of plant-based meat
19 January 2022

The start-up La Vie™ raises €25M and sets out to conquer the world with its new generation of plant-based meat

The first record raising of €25M in Series A financing from investment funds led by Seventure, and international celebrities that are committed to protecting the planet. This...

Read the press release
Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge
13 January 2022

Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge

DERMALA, a consumer dermatology company that develops novel treatments for chronic skin conditions, announces the brand's Grand Prize recognition in the global pitch...

Read more
MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.
15 December 2021

MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.

MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing...

Read the press release
MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan
17 November 2021

MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan

MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI...

Read the press release
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris
3 November 2021

MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris

MaaT Pharma S.A. ("MaaT Pharma" or the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome2-based ecosystem therapies dedicated to...

Read the press release
Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder
27 October 2021

Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder

Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, today announced that the...

Read the press release
CattleEye Announce $2.5m Seed Investment
14 October 2021

CattleEye Announce $2.5m Seed Investment

Belfast-based livestock monitoring technology company CattleEye announced today that it has closed a $2.5m seed investment round from a syndicate led by Techstart Ventures and...

Read more
Digital Aquaculture Innovator Ecto Raises $7M in Series A Round from Rabobank and Aqua-Spark
14 October 2021

Digital Aquaculture Innovator Ecto Raises $7M in Series A Round from Rabobank and Aqua-Spark

Aquaculture data analytics disrupter Ecto has raised $7 million in financing led by the Rabo Food & Agri Innovation Fund and Aqua-Spark. New investor Seventure Partners also...

Read more